[1] |
GU Yi, WANG Rui, DENG Jie, YANG Yijing, ZHOU Wangke, CHEN Yunuo, CHEN Xiaosong, SHEN Wei, ZHOU Jingyi.
Differential analysis and prognostic diagnostic value of inflammatory biomarkers in liver transplantation in patients with severe hepatitis and cirrhosis
[J]. Laboratory Medicine, 2023, 38(11): 1044-1051.
|
[2] |
WU Sujun, JI Hengtao, PENG Mengle.
Clinical values of IL-18,IL-37,NLRP3 and NK/DC ratio in hepatitis B-related liver cirrhosis
[J]. Laboratory Medicine, 2022, 37(6): 518-523.
|
[3] |
LIU Tingting, LIN Yuting, Mila , LI Xiaoqin.
Correlation between serum IL-33 level and its gene polymorphism and the clinical outcome of HBV infection
[J]. Laboratory Medicine, 2021, 36(11): 1101-1105.
|
[4] |
OU Yuanzhu, GONG Jingkai, LIN Feiran, TANG Liping, ZHU Yuqing, LIU Jia, WANG Hualiang.
Interference effects of hemoglobin,bilirubin and chyle on the measurement of plasma ammonia by dry chemistry method and enzymatic assay method
[J]. Laboratory Medicine, 2021, 36(11): 1146-1150.
|
[5] |
BIE Lihan, FANG Meng, FENG Huijuan, LU Zhicheng, GAO Chunfang.
Role of sialylated haptoglobin for the auxiliary diagnosis of hepatitis B-related hepatocellular carcinoma
[J]. Laboratory Medicine, 2020, 35(11): 1147-1152.
|
[6] |
LI Jinghua, ZHAO Wei, TONG Jingjing, ZHANG Tie, CAO Yongtong.
Risk factors of decompensated liver cirrhosis in primary biliary cirrhosis
[J]. Laboratory Medicine, 2018, 33(5): 399-403.
|
[7] |
YE Zhenxuan, YANG Biwei, ZHOU Wenjing, LIU Qiang, LI Hongmei, ZHANG Haiyan, REN Zhijing, ZHANG Hua.
Screening of specific anti-mitochondrial antibody-M2 in 36 459 healthy subjects in Guiyang
[J]. Laboratory Medicine, 2018, 33(3): 205-208.
|
[8] |
KANG Haiyan, HAO Ruofei, REN Ciju.
Relationship between angiotensin Ⅱ level and the severity of liver cirrhosis
[J]. Laboratory Medicine, 2018, 33(12): 1112-1115.
|
[9] |
LIANG Dongyu, HOU Yanqiang, LOU Xiaoli.
Relationship of DcR3 expression with Fas expression in patients with chronic hepatitis B,liver cirrhosis and liver cancer
[J]. Laboratory Medicine, 2017, 32(3): 178-181.
|
[10] |
FU Haitao, YANG Min, HUANG Fenglou, LIANG Yan, ZHONG Renqian.
Change of red blood cell distribution width and its significance in patients with primary biliary cirrhosis
[J]. Laboratory Medicine, 2015, 30(9): 871-873.
|
[11] |
CAI Yiting, HUANG Sheng, XIE Songye.
Analysis on the positive rate of M2 anti-mitochondrial antibodies in physical examine screening in Shanghai
[J]. Laboratory Medicine, 2015, 30(3): 214-218.
|
[12] |
LI Feng, WEI Qun, HUANG Dongfeng, ZHANG Hon.
Expressions and significance of gp96 and Mcl-1 in liver cirrhosis and hepatocellular carcinoma tissues
[J]. Laboratory Medicine, 2015, 30(2): 185-190.
|
[13] |
ZHANG Haiping, YAN Huiping, ZHANG Xin, ZHAO Dantong, MA Yinxue, SUN Limei, LI Zhuomin..
Automatic ELISA system for the detection of anti-mitochondrial M2 antibody and its clinical significance
[J]. Laboratory Medicine, 2015, 30(12): 1234-1237.
|
[14] |
YANG Jingjing,JIANG Hongmin,TANG Aiguo..
The significance of fibronectin detection in hepatofibrosis
[J]. , 2014, 29(4): 331-336.
|
[15] |
WANG Fengyuan, ZHANG Linhua, LAI Weiqiang.
The significance of the combined detection of AFP and ferritin with serum hepatic fibrosis indices in Child-Pugh classification among patients with liver cirrhosis
[J]. , 2014, 29(12): 1222-1225.
|